Efficacy of antiviral therapy during the second or the third trimester for preventing mother-to-child hepatitis B virus transmission: a systematic review and meta-analysis

For pregnant women with high viral load, antiviral therapy has been administered in addition to active and passive immune prophylaxis as a crucial adjunctive therapy to interrupt mother-to-child hepatitis B virus (HBV) transmission (MTCT). However, the time of antiviral therapy onset remains controv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiuhan, Zhong, Xiaozhu, Liao, Huihua, Lai, Yongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032012/
https://www.ncbi.nlm.nih.gov/pubmed/32074216
http://dx.doi.org/10.1590/S1678-9946202062013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032012/
https://www.ncbi.nlm.nih.gov/pubmed/32074216
http://dx.doi.org/10.1590/S1678-9946202062013

Ejemplares similares